Biomerica (NASDAQ:BMRA) Issues Quarterly Earnings Results

Biomerica (NASDAQ:BMRA) issued its quarterly earnings results on Monday. The company reported ($0.06) EPS for the quarter, Zacks reports. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.

Biomerica Trading Up 3.4 %

Shares of Biomerica stock traded up $0.02 during trading on Monday, reaching $0.55. The company’s stock had a trading volume of 65,689 shares, compared to its average volume of 2,214,404. Biomerica has a one year low of $0.24 and a one year high of $1.27. The stock has a 50-day moving average price of $0.66 and a two-hundred day moving average price of $0.47. The stock has a market capitalization of $10.14 million, a P/E ratio of -1.63 and a beta of 0.37.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.